147 related articles for article (PubMed ID: 10837490)
1. Novel gain-of-function mutations of platelet glycoprotein IBalpha by valine mutagenesis in the Cys209-Cys248 disulfide loop. Functional analysis under statis and dynamic conditions.
Dong J; Schade AJ; Romo GM; Andrews RK; Gao S; McIntire LV; López JA
J Biol Chem; 2000 Sep; 275(36):27663-70. PubMed ID: 10837490
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
[TBL] [Abstract][Full Text] [Related]
3. The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding.
Li CQ; Dong JF; López JA
Thromb Haemost; 2002 Oct; 88(4):673-7. PubMed ID: 12362242
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding.
Dong J; Ye P; Schade AJ; Gao S; Romo GM; Turner NT; McIntire LV; López JA
J Biol Chem; 2001 May; 276(20):16690-4. PubMed ID: 11279169
[TBL] [Abstract][Full Text] [Related]
5. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
Peng Y; Berndt MC; Cruz MA; López JA
Blood; 2004 Dec; 104(13):3971-8. PubMed ID: 15319289
[TBL] [Abstract][Full Text] [Related]
6. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex.
Shen Y; Romo GM; Dong JF; Schade A; McIntire LV; Kenny D; Whisstock JC; Berndt MC; López JA; Andrews RK
Blood; 2000 Feb; 95(3):903-10. PubMed ID: 10648402
[TBL] [Abstract][Full Text] [Related]
7. Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor.
Arya M; Kolomeisky AB; Romo GM; Cruz MA; López JA; Anvari B
Biophys J; 2005 Jun; 88(6):4391-401. PubMed ID: 15764659
[TBL] [Abstract][Full Text] [Related]
8. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
9. Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ibalpha using optical tweezers.
Arya M; López JA; Romo GM; Dong JF; McIntire LV; Moake JL; Anvari B
Lasers Surg Med; 2002; 30(4):306-12. PubMed ID: 11948601
[TBL] [Abstract][Full Text] [Related]
10. Gain of von Willebrand factor-binding function by mutagenesis of a species-conserved residue within the leucine-rich repeat region of platelet glycoprotein Ibalpha.
Peng Y; Shrimpton CN; Dong JF; López JA
Blood; 2005 Sep; 106(6):1982-7. PubMed ID: 15933060
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion.
Schade AJ; Arya M; Gao S; Diz-Küçükkaya R; Anvari B; McIntire LV; López JA; Dong JF
Biochemistry; 2003 Feb; 42(7):2245-51. PubMed ID: 12590614
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
14. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
[TBL] [Abstract][Full Text] [Related]
15. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.
Murata M; Russell SR; Ruggeri ZM; Ware J
J Clin Invest; 1993 May; 91(5):2133-7. PubMed ID: 8486780
[TBL] [Abstract][Full Text] [Related]
16. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
Ward CM; Andrews RK; Smith AI; Berndt MC
Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the C-terminal flanking sequence of platelet glycoprotein Ib alpha using canine-human chimeras.
Shen Y; Dong Jf JF; Romo GM; Arceneaux W; Aprico A; Gardiner EE; López JA; Berndt MC; Andrews RK
Blood; 2002 Jan; 99(1):145-50. PubMed ID: 11756164
[TBL] [Abstract][Full Text] [Related]
18. Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations.
Tait AS; Cranmer SL; Jackson SP; Dawes IW; Chong BH
Blood; 2001 Sep; 98(6):1812-8. PubMed ID: 11535515
[TBL] [Abstract][Full Text] [Related]
19. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
20. Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239 --> Val) reported in patients with platelet-type von Willebrand disease.
Moriki T; Murata M; Kitaguchi T; Anbo H; Handa M; Watanabe K; Takahashi H; Ikeda Y
Blood; 1997 Jul; 90(2):698-705. PubMed ID: 9226170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
